Takeharu Sakamoto

Dr. Takeharu Sakamoto

Kanazawa University
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell Metabolism
Verified
Journal Article
Closed access
SOSatotaka Omori
Satotaka Omori
TWTeh-Wei Wang
Teh-Wei Wang
YJYoshikazu Johmura
Yoshikazu Johmura
TKTomomi Kanai
Tomomi Kanai
YNYasuhiro Nakano
Yasuhiro Nakano
MNMakoto Nakanishi
Makoto Nakanishi

28 April 2009 in Genes to Cells
Verified
Journal Article
Open access
PDF file
TSTakeharu Sakamoto
Takeharu Sakamoto
MSMotoharu Seiki
Motoharu Seiki
Membrane type‐1 matrix metalloproteinase (MT1‐MMP) is a proinvasive protease that regulates various cellular functions as evidenced by myriad defects in different types of cells and tissues in MT1‐MMP‐deficient (MT1−/–) mice. Here we demonstrate that MT1−/– mice exhibit fewer infiltrating macrophages into sites of inflammation. MT1−/–macrophages exhibited a reduced ability to invade reconstituted basement membrane (Matrigel) and invasion by wild type (WT) macrophages was inhibited by a synthetic MMP inhibitor (BB94) to a level similar to that of MT1−/– cells. The rate of migration of MT1−/– macrophages was also low compared to that of the WT cells and re‐expression of MT1‐MMP in MT1−/– macrophages reconstituted their migratory activity. Unexpectedly, however, BB94 did not inhibit the migration of WT macrophages. The migration‐boosting activity of MT1‐MMP is retained in a mutant that lacks most of the extracellular portion including the catalytic and hemopexin‐like domains. In contrast, deletion of the cytoplasmic (CP) tail abolished the activity completely. Thus, we have demonstrated that MT1‐MMP regulates macrophages via its invasion‐promoting protease activity as well as its CP‐dependent non‐proteolytic activity to boost cell migration.

1 April 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TSTakeharu Sakamoto
Takeharu Sakamoto
DNDaigo Niiya
Daigo Niiya
MSMotoharu Seiki
Motoharu Seiki
Hypoxia inducible factor-1 (HIF-1) is a key transcription factor required for cellular adaptation to hypoxia, although its physiological roles and activation mechanisms during normoxia have not been studied sufficiently. The Warburg effect, which is a hallmark of malignant tumors that is characterized by increased activity of aerobic glycolysis, accompanies activation of HIF-1 during normoxia. Besides tumor cells that have multiple genetic and epigenetic alterations, normal macrophages also use glycolysis for ATP production by depending upon elevated HIF-1 activity even during normoxia. We recently found that activity of factor inhibiting HIF-1 (FIH-1) is specifically suppressed in macrophages by a nonproteolytic activity of membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14). Thus, MT1-MMP expressed in macrophages plays a significant role in regulating HIF-1 activity during normoxia. In the light of this finding, we examined here whether MT1-MMP contributes to the Warburg effect of tumor cells. All the tumor cell lines that express MT1-MMP exhibit increased glycolytic activity, and forced expression of MT1-MMP in MT1-MMP-negative tumor cells is sufficient to induce the Warburg effect. The cytoplasmic tail of MT1-MMP mediates the stimulation of aerobic glycolysis by increasing the expression of HIF-1 target genes. Specific intervention of the MT1-MMP-mediated activation of HIF-1 in tumor cells retarded tumor growth in mice. Systemic administration of a membrane-penetrating form of the cytoplasmic tail peptide in mice to inhibit HIF-1 activation competitively also exhibited a therapeutic effect on tumors.

1 May 2007 in Cancer Research
Verified
Journal Article
Open access
PDF file
KTKaori Taniwaki
Kaori Taniwaki
HFHiroshi Fukamachi
Hiroshi Fukamachi
KKKiyoshi Komori
Kiyoshi Komori
YOYohei Ohtake
Yohei Ohtake
TNTakahiro Nonaka
Takahiro Nonaka
IYIkuo Yana
Ikuo Yana
Matrix metalloproteinase-2 (MMP-2) is a stroma-derived MMP belonging to the type IV collagenase family. It is believed to mediate tumor cell behavior by degrading deposits of type IV collagen, a major component of the basement membrane. The membrane type 1-MMP (MT1-MMP) is a highly potent activator of MMP-2 and is expressed in many tumor and stromal cells. However, the roles played by stromal MMP-2 in tumor progression in vivo remain poorly understood. We established a colon epithelial cell line from an Mt1-mmp−/− mouse strain and transfected these cells with an inducible expression system for MT1-MMP (MT1rev cells). Following s.c. implantation into Mmp-2+/+ mice and induction of MT1-MMP expression, MT1rev cells grew rapidly, whereas they grew very slowly in Mmp-2−/− mice, even in the presence of MT1-MMP. This MT1-MMP–dependent tumor growth of MT1rev cells was enhanced in Mmp-2−/− mice as long as MMP-2 was supplied via transfection or coimplantation of MMP-2–positive fibroblasts. MT1rev cells cultured in vitro in a three-dimensional collagen gel matrix also required the MT1-MMP/MMP-2 axis for rapid proliferation. MT1rev cells deposit type IV collagen primarily at the cell-collagen interface, and these deposits seem scarce at sites of invasion and proliferation. These data suggest that cooperation between stroma-derived MMP-2 and tumor-derived MT1-MMP may play a role in tumor invasion and proliferation via remodeling of the tumor-associated basement membrane. To our knowledge, this is the first study demonstrating that MT1-MMP–dependent tumor growth in vivo requires stromal-derived MMP-2. It also suggests that MMP-2 represents a potential target for tumor therapeutics. [Cancer Res 2007;67(9):4311–9]

1 September 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TSTakeharu Sakamoto
Takeharu Sakamoto
MSMotoharu Seiki
Motoharu Seiki
Most cells produce ATP in the mitochondria by oxidative phosphorylation. However, macrophages, which are major players in the innate immune system, use aerobic glycolysis to produce ATP. HIF-1 (hypoxia-inducible factor-1) regulates expression of glycolysis-related genes and maintains macrophage glycolytic activity. However, it is unclear how HIF-1 activity is maintained in macrophages during normoxia. In this study, we found that macrophages lacking membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14), a potent invasion-promoting protease, exhibited considerably lower ATP levels than wild-type cells. HIF-1 was activated by an unanticipated function of MT1-MMP, which led to the stimulation of ATP production via glycolysis. The cytoplasmic tail of MT1-MMP bound to FIH-1 (factor inhibiting HIF-1), which led to the inhibition of the latter by its recently identified inhibitor, Mint3/APBA3. We have thus identified a new function of MT1-MMP to mediate production of ATP so as to support energy-dependent macrophage functions by a previously unknown non-proteolytic mechanism.

24 June 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
FNFumie Nakasuka
Fumie Nakasuka
Sho TabataSho Tabata
Sho Tabata
TSTakeharu Sakamoto
Takeharu Sakamoto
Akiyoshi HirayamaAkiyoshi Hirayama
Akiyoshi Hirayama
HEHiromichi Ebi
Hiromichi Ebi
TSTomoyoshi Soga
Tomoyoshi Soga
Epithelial–mesenchymal transition (EMT)—a fundamental process in embryogenesis and wound healing—promotes tumor metastasis and resistance to chemotherapy. While studies have identified signaling components and transcriptional factors responsible in the TGF-β-dependent EMT, whether and how intracellular metabolism is integrated with EMT remains to be fully elucidated. Here, we showed that TGF-β induces reprogramming of intracellular amino acid metabolism, which is necessary to promote EMT in non-small cell lung cancer cells. Combined metabolome and transcriptome analysis identified prolyl 4-hydroxylase α3 (P4HA3), an enzyme implicated in cancer metabolism, to be upregulated during TGF-β stimulation. Further, knockdown of P4HA3 diminished TGF-β-dependent changes in amino acids, EMT, and tumor metastasis. Conversely, manipulation of extracellular amino acids induced EMT-like responses without TGF-β stimulation. These results suggest a previously unappreciated requirement for the reprogramming of amino acid metabolism via P4HA3 for TGF-β-dependent EMT and implicate a P4HA3 inhibitor as a potential therapeutic agent for cancer.